Home > Journals > The Quarterly Journal of Nuclear Medicine and Molecular Imaging

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

THE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Hybrid journal


Affiliated to the Society of Radiopharmaceutical Sciences and to the International Research Group of Immunoscintigraphy
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SCIE), Scopus
Impact Factor 1.560


Quarterly

pISSN 1824-4785

eISSN 1827-1936

Most read articles over the last three weeks

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2022 September;66(3):194-205
The role of PET/CT in connective tissue disorders: systemic sclerosis, Sjögren’s syndrome and systemic lupus erythematosus
Andrea GUARNERI, Elisabetta PERRONE, Silvia L. BOSELLO, Maria A. D’AGOSTINO, Lucia LECCISOTTI *

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2020 June;64(2):152-61
Immunoscore and its introduction in clinical practice
Jérôme GALON *, Anastasia LANZI

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2022 September;66(3):182-93
The role of PET/CT in large vessel vasculitis and related disorders: diagnosis, extent evaluation and assessment of therapy response
François JAMAR *, Lars C. GORMSEN, Halil YILDIZ, Riemer H. SLART, Kornelis S. van der GEEST, Olivier GHEYSENS

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2022 September;66(3):206-17
The role of PET imaging in inflammatory bowel diseases: state-of-the-art review
Pierre LOVINFOSSE *, Roland HUSTINX

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2022 June;66(2):93-103
An essential practice summary of the new EANM guidelines for parathyroid imaging
Petra PETRANOVIĆ OVČARIČEK *, Luca GIOVANELLA, Elif HINDIE, Martin W. HUELLNER, Jean-Noël TALBOT, Frederik A. VERBURG

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2022 September;66(3):234-44
[18F]FDG PET/CT in rheumatoid arthritis
Richard N. GRAHAM *, Emmanouil PANAGIOTIDIS

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 December;63(4):355-70
CT radiomics and PET radiomics: ready for clinical implementation?
Marta BOGOWICZ *, Diem VUONG, Martin W. HUELLNER, Matea PAVIC, Nicolaus ANDRATSCHKE, Hubert S. GABRYS, Matthias GUCKENBERGER, Stephanie TANADINI-LANG

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2022 June;66(2):104-15
Integration of molecular imaging in the personalized approach of patients with adrenal masses
Margherita LORUSSO, Vittoria RUFINI, Carmela DE CREA *, Francesco PENNESTRÌ, Rocco BELLANTONE, Marco RAFFAELLI

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2021 December;65(4):402-9
Prognostic value of interim FDG PET-CT in patients older than 60 years with diffuse large B-cell lymphoma treated by PMitCEBO plus rituximab. Comparison between Deauville 5-point scale and International Harmonization Project criteria
Naelle LOMBION, Philippe ROBIN, Adrian TEMPESCUL, Pierre-Yves LE ROUX, Ulrike SCHICK, Gaëlle GUILLERM, Jean-Christophe IANOTTO, Christian BERTHOU, Pierre-Yves SALAÜN, Ronan ABGRAL *

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2020 September;64(3):278-90
Nuclear medicine radiomics in precision medicine: why we can’t do without artificial intelligence
Wyanne A. NOORTMAN *, Dennis VRIENS, Willem GROOTJANS, Qian TAO, Lioe-Fee de GEUS-OEI, Floris H. VAN VELDEN

top of page